An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma
针对 ALK 受体的抗体-药物偶联物在神经母细胞瘤临床前模型中显示出疗效
期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.aau9732
Renata Sano, Kateryna Krytska, Colleen E Larmour, Pichai Raman, Daniel Martinez, Gwenda F Ligon, Jay S Lillquist, Ulisse Cucchi, Paolo Orsini, Simona Rizzi, Bruce R Pawel, Diego Alvarado, Yael P Mossé